Form Comparison

Extended-Release Melatonin vs Immediate-Release Melatonin

How extended-release melatonin and immediate-release melatonin differ in potency, absorption, tolerance, and cost.

This page contains affiliate links. Titrate earns a small commission when you purchase through them, at no cost to you. This does not affect our recommendations.

Quick verdict. Immediate-release melatonin peaks within an hour and is cleared within a few, which suits trouble falling asleep, jet lag, and circadian shifting, where 0.5 mg timed correctly works as well as bigger doses. Extended-release keeps levels up through the night and is licensed in the EU at 2 mg for primary insomnia in adults 55 and older. Choose immediate-release for sleep onset and body-clock problems, extended-release for waking during the night, especially in older adults.

Side by Side

Extended-Release Melatonin Immediate-Release Melatonin
Absorption Variable Variable
How it is absorbed Formulated to release over several hours, keeping blood levels elevated through the night to mimic the endogenous profile. Rapidly absorbed with oral bioavailability of roughly 9-33% due to first-pass hepatic metabolism by CYP1A2. Peaks within about an hour; half-life under an hour.
Typical dose 2 mg (licensed prolonged-release dose in the EU for adults 55 and older) 0.5-5 mg; 0.5 mg is enough for circadian phase shifting
Common uses sleep maintenance, older adults with low endogenous melatonin jet lag, delayed sleep phase, sleep onset
Side effects Morning grogginess if taken late. Next-day grogginess at higher doses, headache, vivid dreams.
Cost Low Low
Also called prolonged-release melatonin, time-release melatonin, Circadin fast-release melatonin

When to Choose Extended-Release Melatonin

Choose extended-release melatonin when the problem is staying asleep rather than falling asleep. Prescription-grade prolonged-release melatonin is licensed in the EU for primary insomnia in adults 55 and older.

Extended-Release Melatonin

Better matched to waking in the night, and mainly studied in adults over 55.

What to look for: 1-2 mg prolonged-release tablets. Gummies and liquids cannot be extended release.

Find on iHerb Affiliate link

When to Choose Immediate-Release Melatonin

Choose immediate-release melatonin when the problem is falling asleep or shifting your body clock. For circadian shifting, timing matters more than dose. Actual content often differs from the label.

Immediate-Release Melatonin

For shifting the clock and for falling asleep. Small doses do the work.

What to look for: 0.3-1 mg tablets, USP Verified where available. Split larger tablets if that is all you can find.

Find on iHerb Affiliate link

Products on Titrate

2,685 of the 214,745 labels in the NIH Dietary Supplement Label Database list melatonin as an active ingredient (1,519 on market). 1,700 are sold as melatonin products by name.

Open supplement search

Melatonin does not have its own search category yet. Each product above links to its full label in the NIH database.

Related

References

NIH National Center for Complementary and Integrative Health. Melatonin: What You Need To Know.

Zhdanova IV, et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730.

Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520.

Burgess HJ, et al. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95(7):3325-3331.

Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.

Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-281.

Sateia MJ, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349.

Lelak K, et al. Pediatric Melatonin Ingestions: United States, 2012-2021. MMWR Morb Mortal Wkly Rep. 2022;71(22):725-729.

Cohen PA, et al. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329(16):1401-1402.